Pacira BioSciences, Inc. Common Stock (NASDAQ: PCRX) last traded at $24.67, up 3.52% on the session. The quote above updates while this page is open; the figures below are drawn from Pacira BioSciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
Pacira BioSciences, Inc. Common Stock trades on NASDAQ under the ticker PCRX. Its market capitalisation is $983.39 million.
Valuation measures for Pacira BioSciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $983.39M |
|---|---|
| Enterprise value | $1.35B |
| P/E ratio | 68.53 |
| Price / sales | 1.32 |
| Price / book | 1.46 |
| Beta | 0.35 |
Trailing-twelve-month figures tagged in Pacira BioSciences, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $746.16M |
|---|---|
| Net income (TTM) | $14.64M |
| EPS (TTM) | $0.360 |
| Operating margin | 2.66% |
| Return on equity | 2.18% |
| Cash | $205.88M |
Range and volume for PCRX over the past 52 weeks.
| 52-week high | $27.66 |
|---|---|
| 52-week low | $18.80 |
| Volume | 421.1K |
| Average volume | 556.7K |
| Previous close | $23.83 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.